AZGP1 and coronary artery disorder: As shown in Figure 1(a), serum ZAG concentrations were significantly decreased in the CAD (6.64 ± 1.13 vs. 7.56 ± 1.19 μg/mL) and NCAD groups (6.79 ± 1.03 vs. 7.56 ± 1.19 μg/mL) compared to the control group (P<0.05).